Clinical Trial Update: Cerebral Dysfunction in Chronic ITPwith High Risk of Serious Bleeding Excluding Intracranial Hemorrhage.

View source ↗

Summary

This document provides an update on a clinical trial evaluating cerebral dysfunction risk in patients with chronic immune thrombocytopenia who are at high risk …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Ain Shams University | Conditions: Chronic Thrombocytopenia | Status: UNKNOWN